Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1987 Jul 15;65(14):706-12.
doi: 10.1007/BF01875510.

[Effectiveness of gamma interferon and alpha interferon in hairy cell leukemia]

[Article in German]

[Effectiveness of gamma interferon and alpha interferon in hairy cell leukemia]

[Article in German]
N Niederle et al. Klin Wochenschr. .

Abstract

Six patients with hairy-cell leukemia were treated with gamma-(IFN-gamma) and alpha-(IFN-alpha-2b) interferon; 3-35 months following splenectomy, treatment was started with 4 X 10(6) U/m2 IFN-gamma sc (iv) every second day for 9-35 weeks. Although the white blood cell counts decreased during therapy from 4.1-49 X 10(9)/l to 1.5-43 X 10(9)/l, no hematological or clinical improvement was obtained. Subsequently (interval 0-13 weeks), IFN-alpha-2b was given at an initial dose of 4 X 10(6) U/m2 sc every second day to all patients. After a treatment period corresponding to that of IFN-gamma administration, a significant hematological improvement was observed in five patients (one early death due to pulmonary embolism). At the last follow-up (9-14 months after start of treatment; maintenance therapy, 1 X 10(6) U every second day), these patients exhibited normal peripheral blood cell counts, and in bone marrow biopsy specimens a marked decrease of hairy cells was seen (1 CR, 3 PR, 1 MR). Adverse reactions including fever, headache, nausea, dryness of the mouth, myalgia, and fatigue did not significantly differ between the two interferon preparations. Whereas IFN-gamma is unlikely to have any significant impact on the course of hairy cell leukemia, IFN-alpha-2b does result in improvement of hematological values and well-being in almost all patients.

PubMed Disclaimer

Similar articles

Cited by

  • [Therapeutic procedure in hairy cell leukemia].
    von Wussow P. von Wussow P. Klin Wochenschr. 1987 Jul 15;65(14):677-80. doi: 10.1007/BF01875504. Klin Wochenschr. 1987. PMID: 3114549 German. No abstract available.
  • [Beta interferon therapy in hairy cell leukemia].
    von Wussow P, Dühlmann J, Grethlein T, Hirschmann WD, Hügl E, Koch O, Martin WR, Pees HW, Urbanitz W, Freund M. von Wussow P, et al. Klin Wochenschr. 1987 Jul 15;65(14):688-90. doi: 10.1007/BF01875507. Klin Wochenschr. 1987. PMID: 3306139 Clinical Trial. German.

References

    1. Br J Cancer. 1985 Jul;52(1):21-9 - PubMed
    1. Dtsch Med Wochenschr. 1986 Jan 10;111(2):64-70 - PubMed
    1. Blood. 1986 Apr;67(4):937-42 - PubMed
    1. Semin Oncol. 1984 Dec;11(4 Suppl 2):458-71 - PubMed
    1. Schweiz Med Wochenschr. 1985 Feb 16;115(7):235-8 - PubMed

Publication types

LinkOut - more resources